Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -17 | -14 | N/A |
| Accounts payable and accrued liabilities | 0 | 2 | N/A |
| Other Working Capital | 0 | 2 | N/A |
| Other Operating Activity | 0 | -2 | 0 |
| Operating Cash Flow | $-17 | $-12 | $N/A |
| Cash Flows From Investing Activities | |||
| Investing Cash Flow | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 19 | 11 | 0 |
| Financing Cash Flow | $19 | $11 | $N/A |
| Beginning Cash Position | 0 | 1 | N/A |
| End Cash Position | 2 | 0 | N/A |
| Net Cash Flow | $2 | $-1 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -17 | -12 | N/A |
| Free Cash Flow | -17 | -12 | 0 |